Cargando…
What’s New in Critical Illness and Injury Science? Evidence and limitations for using S100β to diagnose and risk stratify critically ill patients with delirium
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664040/ https://www.ncbi.nlm.nih.gov/pubmed/38023579 http://dx.doi.org/10.4103/ijciis.ijciis_51_23 |
| _version_ | 1785138532949426176 |
|---|---|
| author | Miller, Andrew C. |
| author_facet | Miller, Andrew C. |
| author_sort | Miller, Andrew C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10664040 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106640402023-07-01 What’s New in Critical Illness and Injury Science? Evidence and limitations for using S100β to diagnose and risk stratify critically ill patients with delirium Miller, Andrew C. Int J Crit Illn Inj Sci Editorial Wolters Kluwer - Medknow 2023 2023-09-21 /pmc/articles/PMC10664040/ /pubmed/38023579 http://dx.doi.org/10.4103/ijciis.ijciis_51_23 Text en Copyright: © 2023 International Journal of Critical Illness and Injury Science https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Editorial Miller, Andrew C. What’s New in Critical Illness and Injury Science? Evidence and limitations for using S100β to diagnose and risk stratify critically ill patients with delirium |
| title | What’s New in Critical Illness and Injury Science? Evidence and limitations for using S100β to diagnose and risk stratify critically ill patients with delirium |
| title_full | What’s New in Critical Illness and Injury Science? Evidence and limitations for using S100β to diagnose and risk stratify critically ill patients with delirium |
| title_fullStr | What’s New in Critical Illness and Injury Science? Evidence and limitations for using S100β to diagnose and risk stratify critically ill patients with delirium |
| title_full_unstemmed | What’s New in Critical Illness and Injury Science? Evidence and limitations for using S100β to diagnose and risk stratify critically ill patients with delirium |
| title_short | What’s New in Critical Illness and Injury Science? Evidence and limitations for using S100β to diagnose and risk stratify critically ill patients with delirium |
| title_sort | what’s new in critical illness and injury science? evidence and limitations for using s100β to diagnose and risk stratify critically ill patients with delirium |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664040/ https://www.ncbi.nlm.nih.gov/pubmed/38023579 http://dx.doi.org/10.4103/ijciis.ijciis_51_23 |
| work_keys_str_mv | AT millerandrewc whatsnewincriticalillnessandinjuryscienceevidenceandlimitationsforusings100btodiagnoseandriskstratifycriticallyillpatientswithdelirium |